Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Vereecke

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Annals of the Rheumatic Diseases|April 5, 2018
Tumour necrosis factor: out of my heart!Lars Vereecke, Dirk Elewaut
Nature Reviews. Rheumatology|August 18, 2017
Spondyloarthropathies: Ruminococcus on the horizon in arthritic diseaseLars Vereecke, Dirk Elewaut
The FEBS Journal|March 25, 2024
A guide to germ-free and gnotobiotic mouse technology to study health and diseaseMaude Jans, Lars Vereecke
Trends in Microbiology|May 7, 2025
Physiological drivers of pks+ E. coli in colorectal cancerMaude Jans, Lars Vereecke
Trends in Immunology|March 11, 2025
New thoughts on the gut-immune axis of arthritisAlexandra Thiran, Lars Vereecke
Trends in Molecular Medicine|July 12, 2011
Enterocyte death and intestinal barrier maintenance in homeostasis and diseaseLars Vereecke, Rudi Beyaert, Geert van Loo
Biochemical Society Transactions|July 27, 2011
Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune diseaseLars Vereecke, Rudi Beyaert, Geert van Loo
Trends in Immunology|August 3, 2016
Cellular Functions of Optineurin in Health and DiseaseKarolina Slowicka, Lars Vereecke, Geert van Loo
Trends in Immunology|August 1, 2009
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathologyLars Vereecke, Rudi Beyaert, Geert van Loo
Biochemical Pharmacology|October 20, 2020
Targeting neutrophils in asthma: A therapeutic opportunity?Joyceline De Volder, Lars Vereecke, Guy Joos, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Annals of the Rheumatic Diseases|April 5, 2018
Tumour necrosis factor: out of my heart!Lars Vereecke, Dirk Elewaut
Nature Reviews. Rheumatology|August 18, 2017
Spondyloarthropathies: Ruminococcus on the horizon in arthritic diseaseLars Vereecke, Dirk Elewaut
The FEBS Journal|March 25, 2024
A guide to germ-free and gnotobiotic mouse technology to study health and diseaseMaude Jans, Lars Vereecke
Trends in Microbiology|May 7, 2025
Physiological drivers of pks+ E. coli in colorectal cancerMaude Jans, Lars Vereecke
Trends in Immunology|March 11, 2025
New thoughts on the gut-immune axis of arthritisAlexandra Thiran, Lars Vereecke
Trends in Molecular Medicine|July 12, 2011
Enterocyte death and intestinal barrier maintenance in homeostasis and diseaseLars Vereecke, Rudi Beyaert, Geert van Loo
Biochemical Society Transactions|July 27, 2011
Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune diseaseLars Vereecke, Rudi Beyaert, Geert van Loo
Trends in Immunology|August 3, 2016
Cellular Functions of Optineurin in Health and DiseaseKarolina Slowicka, Lars Vereecke, Geert van Loo
Trends in Immunology|August 1, 2009
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathologyLars Vereecke, Rudi Beyaert, Geert van Loo
Biochemical Pharmacology|October 20, 2020
Targeting neutrophils in asthma: A therapeutic opportunity?Joyceline De Volder, Lars Vereecke, Guy Joos, et al.
Pageof 6